Page 291 - AIDSBK23C
P. 291
Page 291
Table 3 – Pharmacologic Agents for Antiretroviral Therapy
Nucleoside Reverse Transcriptase Inhibitors (NRTI’s)
Abacavir (ABC)
Didanosine (ddI)
Lamivudine (3TC)
Stavudine (d4T)
Zidovudine (ZDV, or AZT)
Nucleotide Reverse Transcriptase Inhibitors
Adefovir (ADV)
Cidofovir (CDV)
Emtricitabine (FTC)
Tenofovir (TDF)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI’s)
Delavirdine (DLV)
Efavirenz (EFV)
Nevirapine (NVP)
Etravirine (ETV) – diarylpyrimidine
Rilpivirine (RPV) – diarylpyrimidine
Protease Inhibitors (PI)
Atazanavir (ATV)
Amprenavir (APV)
Darunavir (DRV)
Fosamprenavir (FPV)
Indinavir (IDV)
Lopinavir (LPV)
Nelfinavir (NFV)
Ritonavir (RTV)
Saquinavir (SQV)
Tipranavir (TPV) – non-peptidic
Cell Fusion Inhibitor
Enfuvirtide
CCR5 Inhibitors
Maraviroc
Vicriviroc
Integrase Inhibitors
Elvitegravir
Raltegravir
Maturation Inhibitor
Bevirimat
